These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26438381)
1. Randomized Questionnaire Based Case-Control Research Study on Evaluation of Sexual Function in Indian Patients Taking Oral Finasteride for Androgenetic Alopecia. Narasimhalu CR Dermatol Ther (Heidelb); 2015 Dec; 5(4):231-234. PubMed ID: 26438381 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia. Tosti A; Piraccini BM; Soli M J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):418-21. PubMed ID: 11763381 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia. Tosti A; Pazzaglia M; Soli M; Rossi A; Rebora A; Atzori L; Barbareschi M; Benci M; Voudouris S; Vena GA Arch Dermatol; 2004 Jul; 140(7):857-8. PubMed ID: 15262698 [TBL] [Abstract][Full Text] [Related]
4. Guidelines on the use of finasteride in androgenetic alopecia. Mysore V; Shashikumar BM Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401 [TBL] [Abstract][Full Text] [Related]
5. Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride. Sorbellini E; Pinto D; Marzani B; Rinaldi F Dermatol Ther (Heidelb); 2018 Jun; 8(2):259-267. PubMed ID: 29574572 [TBL] [Abstract][Full Text] [Related]
6. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Shanshanwal SJ; Dhurat RS Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867 [TBL] [Abstract][Full Text] [Related]
7. Finasteride Topical Delivery Systems for Androgenetic Alopecia. Khan MZU; Khan SA; Ubaid M; Shah A; Kousar R; Murtaza G Curr Drug Deliv; 2018; 15(8):1100-1111. PubMed ID: 29366416 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia. Di Loreto C; La Marra F; Mazzon G; Belgrano E; Trombetta C; Cauci S PLoS One; 2014; 9(6):e100237. PubMed ID: 24959691 [TBL] [Abstract][Full Text] [Related]
9. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Mella JM; Perret MC; Manzotti M; Catalano HN; Guyatt G Arch Dermatol; 2010 Oct; 146(10):1141-50. PubMed ID: 20956649 [TBL] [Abstract][Full Text] [Related]
11. Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey-based, single-centre, controlled study. Haber RS; Gupta AK; Epstein E; Carviel JL; Foley KA J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1393-1397. PubMed ID: 30835851 [TBL] [Abstract][Full Text] [Related]
12. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia. Chiriacò G; Cauci S; Mazzon G; Trombetta C Andrology; 2016 Mar; 4(2):245-50. PubMed ID: 26763726 [TBL] [Abstract][Full Text] [Related]
13. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165 [TBL] [Abstract][Full Text] [Related]
14. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Lee S; Lee YB; Choe SJ; Lee WS Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635 [TBL] [Abstract][Full Text] [Related]
15. Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia. Shin YS; Karna KK; Choi BR; Park JK World J Mens Health; 2019 May; 37(2):157-165. PubMed ID: 30209896 [TBL] [Abstract][Full Text] [Related]
16. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. Gupta AK; Talukder M; Williams G J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431 [TBL] [Abstract][Full Text] [Related]
18. Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach. Ahmed OA; Rizq WY Drug Des Devel Ther; 2018; 12():2259-2265. PubMed ID: 30104862 [TBL] [Abstract][Full Text] [Related]
19. A review of the treatment of male pattern hair loss. York K; Meah N; Bhoyrul B; Sinclair R Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284 [No Abstract] [Full Text] [Related]
20. Finasteride for hair loss: a review. Gupta AK; Venkataraman M; Talukder M; Bamimore MA J Dermatolog Treat; 2022 Jun; 33(4):1938-1946. PubMed ID: 34291720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]